{"id":"W4313247961","doi":"10.2147/cmar.s340719","title":"Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management","year":2022,"lang":"en","type":"review","venue":"Cancer Management and Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; FOLFIRINOX; Gemcitabine; Neoadjuvant therapy; Pancreatic cancer; Oncology; Radiation therapy; Adenocarcinoma; Pancreatic ductal adenocarcinoma; Chemotherapy; Randomized controlled trial; Clinical trial; Internal medicine; Cancer; Irinotecan; Breast cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006418834,0.0004955452,0.002997316,0.001075107,0.0007098713,0.00007427902,0.0006322939,0.0003649501,0.002304873],"category_scores_gemma":[0.0001432157,0.0003773632,0.0005133669,0.0009074236,0.0005361979,0.00005840669,0.001368766,0.001603205,0.00003685803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007971236,"about_ca_system_score_gemma":0.0007041655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001447603,"about_ca_topic_score_gemma":0.0000546947,"domain_scores_codex":[0.9938295,0.0009527699,0.001060901,0.001418169,0.001374218,0.001364382],"domain_scores_gemma":[0.9964353,0.001688196,0.0002125413,0.0009958753,0.0002178947,0.0004501709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000325468,0.0002940339,0.000376984,0.114947,0.003580492,0.0002375745,0.00004905889,1.33488e-7,9.72002e-9,0.002246031,0.04508261,0.8328606],"study_design_scores_gemma":[0.002415442,0.0008766198,0.0004253439,0.01022544,0.004702293,0.00001399949,0.0005573652,0.00006183336,4.411325e-8,0.0003314973,0.9800547,0.0003354108],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002141414,0.939351,0.00001728733,0.001628465,0.0004401795,0.009005886,0.00009207325,0.00006050476,0.04938319],"genre_scores_gemma":[0.000002110287,0.8585611,0.0006800459,0.00008353742,0.0008931187,0.02231157,0.0001692206,0.0001142061,0.1171851],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9349721,"threshold_uncertainty_score":0.9998679,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5196987092176054,"score_gpt":0.5955855729175834,"score_spread":0.07588686369997799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}